Analyst Speak: 

“The Global Point of Care Diagnostics Market was valued at US$ 22.7 Bn in 2018 and is expected to grow at a significant CAGR over six years forecast period 2019-2025 owing to approval for innovative immunoassay technologies by the regulatory”

Precision Business Insights (PBI) in its report titled “Global Point of Care Diagnostics Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2018 and Forecast 2019-2025” assesses the market performance over six years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

Avail Sample Report of the Market @ https://www.precisionbusinessinsights.com/request-sample?product_id=17104

The global point of care diagnostics market was valued at US$ 22.7 Bn in 2018 and growing at a CAGR of 9.1% over the forecast period owing to increasing investments in research and development to miniscule molecular diagnostic tests coupled with advances in laboratory automation techniques. Moreover, introduction of cost effective products in the market and increasing usage of home-based POC procedures, rising prevalence of targeted diseases coupled with advancements in technology are anticipated to drive the growth of the market over the forecast years. However, lack of skilled professionals in APAC and Latin region and frequent product recalls in the market, unfavorable reimbursement policies are expected to restrain the growth of the market over the future years.

Global point of care diagnostics market segmented on the basis of product type, prescription mode, end user, and region.               

Prescription based testing kits segment accounted for higher revenue share

Based on prescription mode, global point of care diagnostics market is segmented into Over-the-counter (OTC) testing kits and Prescription-based testing kits. Prescription based testing kits segment accounted for the largest market share in 2018 and is expected to grow with highest CAGR over the forecast period owing to lack of awareness on POCT devices that are available in OTC in emerging nations and rising incidence rate of lifestyle diseases and growing prevalence of the diseases are expected to drive the growth of the market over the forecast years.

North America holds leading position in Global Point of Care Diagnostics Market 

PBI’s global point of care diagnostics market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. According to regional analysis, North America is expected to account for larger revenue share in 2018 and the same trend is projected to follow over 2019-2025 owing to growing number of products approved in the region and the OTC segment in North America holds significant revenue share due to significant increase in the sales of the OTC in United States in 2018. The increasing incidence of lifestyle diseases and rising support from the government are expected to drive the growth of the market. Asia Pacific and Europe region are driving with significant growth rate over the forecast period owing to developing healthcare infrastructure and increasing awareness among the patients in emerging economies fuels the growth of the market over the future years.

For More Information @ https://www.precisionbusinessinsights.com/market-reports/global-point-of-care-diagnostics-market/

Recent Developments in the Global In Vitro-Diagnostics Market 

In September 2017, Mologic Ltd received CE mark approval for BVPro point of care diagnostic for the detection of bacterial vaginosis
In May 2016, Philips launched handheld diagnosis at the point of care diagnosis help in the detection of a heart attack.

Key player’s profiles in the report are Siemens AG (Germany), Abbott Laboratories, Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), Becton, Dickinson, and Company (U.S.), Mologic Ltd (U.K.), Johnson & Johnson Services Inc. (U.S.), Sinocare, Inc. (China), Roche Diagnostics (U.S.), Nova Biomedical (U.S.), and Instrumentation Laboratory (U.S.) to name a few.

Detailed Segmentation 

By Product Type

Infectious Disease Testing Kits
Cancer/Tumor Markers Testing
Cardio-Metabolic Monitoring Kits
Fertility and Pregnancy Testing Kits
Hematological Testing Kits
Faecal Occult Testing Kits
Glucose Monitoring Kits
Cholesterol Test Strips
Urinalysis Testing Kits
Others

By Prescription Mode  

Over-the-counter (OTC) Testing Kits
Prescription-based Testing Kits 

By End User

Hospitals
Diagnostic Centers
Homecare
Others

Geography 

North America

US
Canada

Europe

Germany
France
UK
Italy
Spain
Russia
Poland
Rest of Europe

Asia-Pacific

Japan
China
India
Australia & New Zealand
ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
South Korea
Rest of Asia-Pacific

Latin America

Brazil
Mexico
Argentina
Venezuela
Rest of Latin America

Middle East and Africa (MEA)

Gulf Cooperation Council (GCC) Countries
Israel
South Africa
Rest of MEA

About Us:
 
Precision Business Insights is one of the leading market research and management consulting firm, run by a group of seasoned and highly dynamic market research professionals with a strong zeal to offer high-quality insights.
 
Contact Us:
 
Shreya Paul
Senior Business Development Executive
Email @ [email protected]
Call @ +1-866-598-1553
Precision Business Insights